Company Filing History:
Years Active: 2021-2024
Title: The Innovations of Lisong Ai: Pioneering Heart Valve Solutions
Introduction: Lisong Ai, an accomplished inventor based in Irvine, California, has significantly contributed to the field of biomedical engineering. With two patents to his name, Ai focuses on advancing heart valve technologies to improve surgical procedures and patient outcomes.
Latest Patents: Ai's most recent innovations include groundbreaking patents for heart valve sealing assemblies. One of his latest inventions is a hybrid heart valve prosthesis designed for quick and easy implantation during surgical procedures. This prosthesis features a substantially non-expandable, non-compressible valve member with a peripheral sealing ring and an expandable stent frame that enables attachment to the annulus without needing sutures. The stent frame, which may be plastically-expandable, is covered with a thin fabric layer and includes secondary sealing structures to prevent paravalvular leakage. Additionally, Ai has developed a prosthetic mitral valve with improved anchors and seal. This innovative valve includes an hourglass-shaped inner frame designed to reduce the gap between the valve leaflets and the frame, thereby minimizing the risk of thrombus formation and enhancing overall functionality.
Career Highlights: Lisong Ai works at Edwards Lifesciences Corporation, a leading company recognized for its focus on heart valve therapy. With his expertise and innovative mindset, Ai has played a crucial role in developing advanced medical devices that address complex cardiovascular challenges.
Collaborations: Throughout his career, Ai has collaborated with talented professionals within the field, including his esteemed coworkers Alexander H. Cooper and Juliet Laura Schwartz. These partnerships have fostered a collaborative environment that encourages innovation and drives progress in heart valve technology.
Conclusion: Lisong Ai continues to be a vital force in the innovation of heart valve technologies. His patents represent significant advancements in the field, aiming to enhance surgical efficiency and improve patient care. As he continues his work at Edwards Lifesciences Corporation, Ai remains committed to pioneering solutions that can transform cardiovascular medicine.